Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Clinics and Practice
|
August 25, 2023
The Constrained-Disorder Principle Assists in Overcoming Significant Challenges in Digital Health: Moving from "Nice to Have" to Mandatory Systems
Noa Hurvitz, Yaron Ilan
European Journal of Human Genetics : EJHG
|
July 19, 2021
Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases
Noa Hurvitz, Henny Azmanov, Asa Kesler, et al.
Frontiers in Aging
|
January 2, 2023
Improving the effectiveness of anti-aging modalities by using the constrained disorder principle-based management algorithms
Noa Hurvitz, Narmine Elkhateeb, Tal Sigawi, et al.
Pediatric Emergency Care
|
March 25, 2020
Factors Associated With Increased Risk of Pediatric Orbital Cellulitis-Who Should Be Scanned?
Lea Ohana-Sarna-Cahan, Noa Hurvitz, Itai Gross, et al.
Current Aging Science
|
April 10, 2025
Variability in Exercise is Linked to Improved Age-related Dysfunctions, Suggesting a Potential Role for the Constrained-Disorder Principle-based Second-Generation Artificial Intelligence System
Ehud Rinott, Tal Sigawi, Noa Hurvitz, et al.
Clinics and Practice
|
July 25, 2024
Investigating the Relationship between Chronic Liver Cirrhosis and Parkinsonism: A Comparative Analysis and a Suggested Diagnostic Scheme
Tal Sigawi, Omer Hamtzany, Noa Hurvitz, et al.
Emerging Infectious Diseases
|
September 18, 2020
Tickborne Relapsing Fever, Jerusalem, Israel, 2004-2018
Saar Hashavya, Itai Gross, Matan Gross, et al.
Journal of Clinical Medicine
|
June 19, 2024
A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy
Noa Hurvitz, Tama Dinur, Shoshana Revel-Vilk, et al.
IBRO Neuroscience Reports
|
March 19, 2026
A feasibility open-label clinical trial utilizing second-generation artificial intelligence based on the constrained-disorder principle in patients with Parkinson's disease
Hillel Lehmann, Henny Azmanov, Yoav Hershkovitz, et al.
Obesity Surgery
|
May 2, 2020
Predicting Weight Loss and Comorbidity Improvement 7 Years Following Laparoscopic Sleeve Gastrectomy: Does Early Weight Loss Matter?
James Tankel, Omer Shlezinger, Michael Neuman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Clinics and Practice
|
August 25, 2023
The Constrained-Disorder Principle Assists in Overcoming Significant Challenges in Digital Health: Moving from "Nice to Have" to Mandatory Systems
Noa Hurvitz, Yaron Ilan
European Journal of Human Genetics : EJHG
|
July 19, 2021
Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases
Noa Hurvitz, Henny Azmanov, Asa Kesler, et al.
Frontiers in Aging
|
January 2, 2023
Improving the effectiveness of anti-aging modalities by using the constrained disorder principle-based management algorithms
Noa Hurvitz, Narmine Elkhateeb, Tal Sigawi, et al.
Pediatric Emergency Care
|
March 25, 2020
Factors Associated With Increased Risk of Pediatric Orbital Cellulitis-Who Should Be Scanned?
Lea Ohana-Sarna-Cahan, Noa Hurvitz, Itai Gross, et al.
Current Aging Science
|
April 10, 2025
Variability in Exercise is Linked to Improved Age-related Dysfunctions, Suggesting a Potential Role for the Constrained-Disorder Principle-based Second-Generation Artificial Intelligence System
Ehud Rinott, Tal Sigawi, Noa Hurvitz, et al.
Clinics and Practice
|
July 25, 2024
Investigating the Relationship between Chronic Liver Cirrhosis and Parkinsonism: A Comparative Analysis and a Suggested Diagnostic Scheme
Tal Sigawi, Omer Hamtzany, Noa Hurvitz, et al.
Emerging Infectious Diseases
|
September 18, 2020
Tickborne Relapsing Fever, Jerusalem, Israel, 2004-2018
Saar Hashavya, Itai Gross, Matan Gross, et al.
Journal of Clinical Medicine
|
June 19, 2024
A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy
Noa Hurvitz, Tama Dinur, Shoshana Revel-Vilk, et al.
IBRO Neuroscience Reports
|
March 19, 2026
A feasibility open-label clinical trial utilizing second-generation artificial intelligence based on the constrained-disorder principle in patients with Parkinson's disease
Hillel Lehmann, Henny Azmanov, Yoav Hershkovitz, et al.
Obesity Surgery
|
May 2, 2020
Predicting Weight Loss and Comorbidity Improvement 7 Years Following Laparoscopic Sleeve Gastrectomy: Does Early Weight Loss Matter?
James Tankel, Omer Shlezinger, Michael Neuman, et al.
Page
of 2